Seeking Alpha

Conatus Pharmaceuticals (CNAT)

There are 3 articles on this stock available only to PRO subscribers.
From other sites
Visit Seeking Alpha's
CNAT vs. ETF Alternatives
Company Description
Conatus Pharmaceuticals Inc is a biotechnology company focused on the development and commercialization of novel medicines to treat liver disease.
Sector: Healthcare
Industry: Biotechnology
Country: United States